Gene Fusion Testing Market, By Category (Diagnostic and Research), By Technology, By Indication, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV6131
|
Published Date
September 2026
|
Pages
392
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Gene Fusion Testing market size was valued at US$ 830.1 Million in 2025, expanding at a CAGR of 13.1% from 2026 to 2033.
The global Gene Fusion Testing market refers to that part of molecular diagnostics and precision medicine that was developed specifically for testing genetic mutations, including gene fusions, occurring during the process of various diseases\' development, including oncology. A gene translocation test is used for identifying protein mutations that result in the development of cancer. As the demand for new technologies has been constantly rising, the global Gene Fusion Testing market has become an integral part of the field of precision medicine, allowing for creating a personalized approach to treating patients based on their genetic background.
The global Gene Fusion Testing market represents a key field for personalizing cancer therapy on the basis of information about genetic abnormalities. There are several technologies that are used in the global Gene Fusion Testing market for the purpose of detecting gene translocations in cases of different kinds of cancer, such as NGS (next generation sequencing), FISH (fluorescence in situ hybridization), and PCR (polymerase chain reaction). These technologies enhance gene fusion detection, supporting accurate diagnosis and targeted cancer treatment decision.
Gene Fusion Testing Market- Market Dynamics
Increasing Cancer Disease Prevalence to Accelerate Market Expansion
The increasing prevalence of cancer is driving demand for gene fusion testing because of the growing number of cancer patients, who increase the need for accurate molecular tests for actionable mutations and for treatment planning in each particular case. For example, in March 2026, according to Eurostat, cancer was the second most common cause of deaths in the EU, and there were about 1.16 million cases (23.9%) out of all deaths in this period. The cancer cases were more common among the elder population, as the standardized death rate was 936.0 cases per 100,000 inhabitants over 65 years of age, while the death rate among the younger population was 62.9 per 100,000 inhabitants under 65 years of age. There were 233.1 cases of cancer per 100,000 inhabitants in the total EU standardized death rate from cancer, while the death rate among males was 302.8 cases and among females was 183.7 cases per 100,000 inhabitants. These trends are expected to accelerate demand for gene fusion testing in cancer diagnosis and treatment planning.
Gene Fusion Testing Market- Segmentation Analysis:
The Global Gene Fusion Testing market is segmented on the basis of Category, Technology, Indication, End User, and Region.
Based on technology, Polymerase Chain Reaction (PCR) holds an important position in the Gene Fusion Testing market due to greater sensitivity and quick turnaround time as well as greater applications in the detection of gene fusions for screening and molecular profiling of cancer patients. For instance, in February 2025, according to a PLOS ONE (Org.), the high-frequency PCR testing method was used for about 3,421 healthcare workers and in around 285,000 oral swab samples. Unvaccinated healthcare workers were mandated to do PCR tests twice a week; all healthcare workers were mandated to do PCR tests twice a week, leading to a total of 17,940 PCR tests and 17,479 in a month at a German care facility conducting continuous surveillance of SARS-CoV-2. These technologies facilitate reliable, efficient, and quick detection of clinically actionable gene fusion events.
Gene Fusion Testing Market- Geographical Insights
Based on region, Asia-Pacific is projected to be the growing region in the global Gene Fusion Testing market due to the rising presence of diagnostic companies and investments in molecular diagnostics. For example, in June 2026, the India Brand Equity Foundation (IBEF) stated that India\'s market for diagnostic devices will achieve ($6,000 million) in 2027, as compared to or $4,000 million) in CY23. There is significant growth in the demand, which offers an opportunity to diagnostic companies to increase their presence in the Indian region. Moreover, India\'s market for medical devices is forecasted to reach from ($15,200 million) in 2025 to ($50,100 million) in 2030 because of the growing demand for healthcare, hospital infrastructure, and insurance coverage. This trend is expected to strengthen diagnostic capabilities and accelerate gene fusion testing adoption across Asia-Pacific.
Singapore Gene Fusion Testing Market - Country Insights
Singapore is developing rapid routes towards approving and regulating companion and molecular diagnostics, and this ensures faster time-to-market and increased adoption of innovations. In August 2025, according to the Singapore Economic Development Board (Gov), Singapore’s ecosystem of companies, either local or global, amounts to a total of more than 400 companies employing over 17,000 individuals, and the topmost MedTech companies of the world include the top 30 MNCs, which are operating in Singapore. These MedTech companies manufacture a total value of more than S$19 billion SGD of high-value medical devices per year, which includes, among others, contact lenses and cardiac implants, and one of the most amazing facts, which is indeed amazing, is that out of the total 30 MNCs, more than 20 companies set up R&D centres in Singapore.
And the nation\'s National Precision Medicine Initiative and SG100K Programme expect Singapore to conduct a detailed analysis of large data points like lifestyles, clinical factors, genomics, and environmental factors of around ten per cent of the total population of Singapore up to 2031, and all of the 100,000 Singaporeans will undergo genomic sequencing and analysis. All of these capabilities go on to facilitate the development of advanced diagnostic technologies, which include AI-based diagnostics that process medical images faster and more accurately, cancer-risk modelling, congenital hearing loss risk prediction, and others.
Gene Fusion Testing Market- Competitive Landscape:
Technological innovations, investments, and finance are key drivers that propel the worldwide Gene Fusion Testing market forward. There are some well-known companies like Roche, Guardant Health, Illumina, Biocartis, and Amoy Diagnostics that are contributing to technology development in order to drive the growth of the global market of gene fusion testing, along with the use of the above-mentioned technology to conduct gene fusion testing. In May 2026, Roche signed an agreement with PathAI, buying the company for $750 million in cash upfront and $300 million in milestones, and this will help Roche be a better competitor in the industry of digital pathology and companion diagnostics using artificial intelligence. These strategic developments are expected to accelerate innovation and expand gene fusion testing capabilities.
Recent Developments:
- In July 2025, Amoy Diagnostics, Riken Genesis, and Precision Medicine Asia have announced that the AmoyDx® Pan Lung Cancer PCR Panel is an approved companion diagnostic for amivantamab and lazertinib in Japan. It is a complete test kit for screening of mutations in various genes like EGFR, ALK, ROS1, KRAS, BRAF, HER2, RET, MET, NTRK1, NTRK2, and NTRK3, including ALK, ROS1, and RET gene fusions.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENE FUSION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Amoy Diagnostics Co., Ltd.
- Arima Genomics, Inc.
- Biocare Medical, LLC
- Biocartis NV
- Caris Life Sciences
- Danaher Corporation
- Empire Genomics, Inc.
- Hoffmann-La Roche Ltd.
- Guardant Health, Inc.
- Illumina, Inc.
- Integrated DNA Technologies, Inc. (ArcherDX)
- Myriad Genetics, Inc.
- Natera, Inc.
- NeoGenomics, Inc.
- OncoDNA SA
- Paragon Genomics, Inc.
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- Others
GLOBAL GENE FUSION TESTING MARKET, BY CATEGORY- MARKET ANALYSIS, 2020 - 2033
- Diagnostic
- Research
GLOBAL GENE FUSION TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Immunohistochemistry (IHC)
- Polymerase Chain Reaction (PCR)
- Fluorescence In-Situ Hybridization (FISH)
- Next-Generation Sequencing (NGS)
GLOBAL GENE FUSION TESTING MARKET, BY INDICATION- MARKET ANALYSIS, 2020 - 2033
- Hematological Malignancies
- Solid Tumors
GLOBAL GENE FUSION TESTING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Academic & Research Centers
- Hospitals and Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Others
GLOBAL GENE FUSION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENT
1. Gene Fusion Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Gene Fusion Testing Market Snippet by Category
2.1.2. Gene Fusion Testing Market Snippet by Technology
2.1.3. Gene Fusion Testing Market Snippet by Indication
2.1.4. Gene Fusion Testing Market Snippet by End User
2.1.5. Gene Fusion Testing Market Snippet by Country
2.1.6. Gene Fusion Testing Market Snippet by Region
2.2. Competitive Insights
3. Gene Fusion Testing Key Market Trends
3.1. Gene Fusion Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Gene Fusion Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Gene Fusion Testing Market Opportunities
3.4. Gene Fusion Testing Market Future Trends
4. Gene Fusion Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Gene Fusion Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Gene Fusion Testing Market Landscape
6.1. Gene Fusion Testing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Gene Fusion Testing Market – By Category
7.1. Overview
7.1.1. Segment Share Analysis, By Category, 2025 & 2033 (%)
7.1.2. Diagnostic
7.1.3. Research
8. Gene Fusion Testing Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
8.1.2. Immunohistochemistry (IHC)
8.1.3. Polymerase Chain Reaction (PCR)
8.1.4. Fluorescence In-Situ Hybridization (FISH)
8.1.5. Next-Generation Sequencing (NGS)
9. Gene Fusion Testing Market – By Indication
9.1. Overview
9.1.1. Segment Share Analysis, By Indication, 2025 & 2033 (%)
9.1.2. Hematological Malignancies
9.1.3. Solid Tumors
10. Gene Fusion Testing Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
10.1.2. Academic & Research Centers
10.1.3. Hospitals and Diagnostic Laboratories
10.1.4. Pharmaceutical and Biotechnology Companies
10.1.5. Others
11. Gene Fusion Testing Market – By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Gene Fusion Testing Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Gene Fusion Testing Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Gene Fusion Testing Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Gene Fusion Testing Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Gene Fusion Testing Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Category, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Gene Fusion Testing Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Amoy Diagnostics Co., Ltd.
12.2.2. Arima Genomics, Inc.
12.2.3. Biocare Medical, LLC
12.2.4. Biocartis NV
12.2.5. Caris Life Sciences
12.2.6. Danaher Corporation
12.2.7. Empire Genomics, Inc.
12.2.8. F. Hoffmann-La Roche Ltd.
12.2.9. Guardant Health, Inc.
12.2.10. Illumina, Inc.
12.2.11. Integrated DNA Technologies, Inc. (ArcherDX)
12.2.12. Myriad Genetics, Inc.
12.2.13. Natera, Inc.
12.2.14. NeoGenomics, Inc.
12.2.15. OncoDNA SA
12.2.16. Paragon Genomics, Inc.
12.2.17. QIAGEN N.V.
12.2.18. Thermo Fisher Scientific Inc.
12.2.19. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENE FUSION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Amoy Diagnostics Co., Ltd.
- Arima Genomics, Inc.
- Biocare Medical, LLC
- Biocartis NV
- Caris Life Sciences
- Danaher Corporation
- Empire Genomics, Inc.
- Hoffmann-La Roche Ltd.
- Guardant Health, Inc.
- Illumina, Inc.
- Integrated DNA Technologies, Inc. (ArcherDX)
- Myriad Genetics, Inc.
- Natera, Inc.
- NeoGenomics, Inc.
- OncoDNA SA
- Paragon Genomics, Inc.
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- Others
GLOBAL GENE FUSION TESTING MARKET, BY CATEGORY- MARKET ANALYSIS, 2020 - 2033
- Diagnostic
- Research
GLOBAL GENE FUSION TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Immunohistochemistry (IHC)
- Polymerase Chain Reaction (PCR)
- Fluorescence In-Situ Hybridization (FISH)
- Next-Generation Sequencing (NGS)
GLOBAL GENE FUSION TESTING MARKET, BY INDICATION- MARKET ANALYSIS, 2020 - 2033
- Hematological Malignancies
- Solid Tumors
GLOBAL GENE FUSION TESTING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Academic & Research Centers
- Hospitals and Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Others
GLOBAL GENE FUSION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Analystview Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
